Conduit Pharmaceuticals: Biotech Pivot, Nasdaq Risk & Reverse Split
The biotechnology sector is often characterized by high risk and high reward, and Conduit Pharmaceuticals (CDT) is currently navigating a particularly challenging period. The company, which underwent a significant transformation … Read More